NATO MULTIMEDIA ACCOUNT

Access NATO’s broadcast-quality video content free of charge

Register

Create an account

Create an account

Check your inbox and enter verification code

We have sent a verification code to your email address. . Enter the code to verify your account. This code will expire in 30 minutes.
Verification code

Didn't receive a code? Send new Code

You have successfully created your account

From now on you can download videos from our website

Subscribe to our newsletter

If you would also like to subscribe to the newsletter and receive our latest updates, click on the button below.

Reset password

Enter the email address you registered with and we will send you a code to reset your password.

Reset password
Check your inbox and enter verification code
We have sent a verification code to your email address. Enter the code to verify your account. This code will expire in 30 minutes.
Verification code

Didn't receive a code? Send new Code

Create a new password

The password must be at least 12 characters long, no spaces, include upper/lowercase letters, numbers and symbols.

Your password has been updated

Click the button to return to the page you were on and log in with your new password.

Colonel D. Lam, Medical Staff Officer of IMS, Mark Laity, Acting NATO Spokesman, and Major General R. van Hoof, Surgeon General of the Belgian Armed Forces [left to right] briefing the press on COMEDS meeting

NATO's senior medical advisory body, the Committee of the Chiefs of Military Medical Services (COMEDS), which consists of surgeons-general from all member nations, medical advisers from NATO's strategic commands and the medical staff officer from NATO's International Military Staff, held an extraordinary meeting on 15 January to share information on possible health risks related to Depleted Uranium.

This body considered all available medical literature and exchanged information on recent actions taken by individual nations. On the basis of this review, the COMEDS concluded that the use of Depleted Uranium was a low-level risk under specific limited circumstances and that there was no evidence of ill-health related to Depleted Uranium among SFOR and KFOR personnel who had served in the Balkans.

Nevertheless, it was important to continue gathering information and to remain active on the issue. To ensure the health of all soldiers serving in NATO-led peacekeeping operations in the Balkans, a common medical policy was adopted. This includes a commitment to examine and assess illness and mortality rates among these people, even though to date no increases have been recorded.

On 16 January, NATO's newly formed Committee on Depleted Uranium, which consists of NATO officials and representatives of past and present SFOR and KFOR contributing nations, met for the first time. Members were briefed on existing medical and scientific evidence concerning the possible health risks of Depleted Uranium. All nations attending indicated their willingness to share information on research currently underway, although several said current information has shown no signs of increased levels of ill-health related to service in the Balkans.